Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6JCya-Oas2em1/Cya
Common Name:
Oas2-KO
Product ID:
S-KO-17570
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Oas2-KO
Strain ID
KOCMP-246728-Oas2-B6J-VB
Gene Name
Oas2
Product ID
S-KO-17570
Gene Alias
Oasl11
Background
C57BL/6JCya
NCBI ID
246728
Modification
Conventional knockout
Chromosome
5
Phenotype
MGI:2180852
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Oas2em1/Cya mice (Catalog S-KO-17570) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000081491
NCBI RefSeq
NM_001347448.1
Target Region
Exon 2
Size of Effective Region
~1.1 kb
Detailed Document
Click here to download >>
Overview of Gene Research
Oas2, short for 2'-5'-oligoadenylate synthetase 2, is an interferon (IFN)-induced antiviral enzyme. It belongs to the OAS family, which also includes OAS1, OAS3, and OAS-like (OASL). Oas2 can generate 2'-5'-linked oligoadenylates upon activation by double-stranded RNA, which is involved in the RNA cleavage pathway and antiviral response system [6,8].

In breast cancer, high Oas2 mRNA expression is associated with favorable prognosis, potentially making it a prognostic biomarker [1]. In psoriasis, Oas2 is overexpressed in lesional skin and serum, and its expression is downregulated by biologics. Silencing Oas2 inhibits keratinocyte proliferation by regulating the cell cycle and suppressing IFN-1-induced phosphorylation of Jak1 and signal transducer and activator of transcription 1, suggesting it may be a therapeutic biomarker [2]. In SARS-CoV-2-related multisystem inflammatory syndrome in children, autosomal recessive deficiencies of Oas2 lead to excessive production of inflammatory cytokines upon viral stimulation, underlying the disease mechanism [3]. In mammary cancer, an activating mutation in Oas2 prevents pregnancy-driven metastases and enhances the effectiveness of checkpoint immunotherapy, establishing it as a therapeutic target [4]. In testicular cancer, upregulating Oas2 by piR-36249 and DHX36 inhibits cancer cell progression [5]. Oas2 also restricts intracellular Mycobacterium tuberculosis replication and enhances pro-inflammatory cytokine secretion [6], and inhibits Zika virus replication through activation of the Type Ι IFN signaling pathway [7].

In conclusion, Oas2 plays crucial roles in multiple disease conditions, including cancer, psoriasis, and infectious diseases. Its functions in these diseases range from being a prognostic biomarker, a therapeutic target, to being involved in the regulation of cell proliferation, cytokine production, and antiviral responses. Studies, especially those with potential loss-of-function models, have significantly contributed to our understanding of Oas2's role in these biological processes and disease conditions.

References:
1. Zhang, Yujie, Yu, Chaoran. 2020. Prognostic characterization of OAS1/OAS2/OAS3/OASL in breast cancer. In BMC cancer, 20, 575. doi:10.1186/s12885-020-07034-6. https://pubmed.ncbi.nlm.nih.gov/32560641/
2. Huang, Yan-Zhou, Zheng, Yu-Xin, Zhou, Yuan, Zheng, Min, Man, Xiao-Yong. 2022. OAS1, OAS2, and OAS3 Contribute to Epidermal Keratinocyte Proliferation by Regulating Cell Cycle and Augmenting IFN-1‒Induced Jak1‒Signal Transducer and Activator of Transcription 1 Phosphorylation in Psoriasis. In The Journal of investigative dermatology, 142, 2635-2645.e9. doi:10.1016/j.jid.2022.02.018. https://pubmed.ncbi.nlm.nih.gov/35305973/
3. Lee, Danyel, Le Pen, Jérémie, Yatim, Ahmad, Zhang, Shen-Ying, Casanova, Jean-Laurent. 2023. Inborn errors of OAS-RNase L in SARS-CoV-2-related multisystem inflammatory syndrome in children. In Science (New York, N.Y.), 379, eabo3627. doi:10.1126/science.abo3627. https://pubmed.ncbi.nlm.nih.gov/36538032/
4. Ho, Wing-Hong Jonathan, Law, Andrew M K, Masle-Farquhar, Etienne, Oakes, Samantha R, Ormandy, Christopher J. 2022. Activation of the viral sensor oligoadenylate synthetase 2 (Oas2) prevents pregnancy-driven mammary cancer metastases. In Breast cancer research : BCR, 24, 31. doi:10.1186/s13058-022-01525-z. https://pubmed.ncbi.nlm.nih.gov/35505346/
5. Wang, Qianqian, Chen, Peize, Wang, Xiaorong, Song, Xiaoyuan, Sun, Fei. 2023. piR-36249 and DHX36 together inhibit testicular cancer cells progression by upregulating OAS2. In Non-coding RNA research, 8, 174-186. doi:10.1016/j.ncrna.2022.12.004. https://pubmed.ncbi.nlm.nih.gov/36710986/
6. Leisching, Gina, Cole, Victoria, Ali, Aus T, Baker, Bienyameen. 2019. OAS1, OAS2 and OAS3 restrict intracellular M. tb replication and enhance cytokine secretion. In International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 80S, S77-S84. doi:10.1016/j.ijid.2019.02.029. https://pubmed.ncbi.nlm.nih.gov/30822544/
7. Liao, Xinzhong, Xie, He, Li, Shilin, Yang, Chunhui, Chen, Limin. 2020. 2', 5'-Oligoadenylate Synthetase 2 (OAS2) Inhibits Zika Virus Replication through Activation of Type Ι IFN Signaling Pathway. In Viruses, 12, . doi:10.3390/v12040418. https://pubmed.ncbi.nlm.nih.gov/32276512/
8. Koul, Amit, Deo, Soumya, Booy, Evan P, Genung, Matthew, McKenna, Sean A. 2019. Impact of double-stranded RNA characteristics on the activation of human 2'-5'-oligoadenylate synthetase 2 (OAS2). In Biochemistry and cell biology = Biochimie et biologie cellulaire, 98, 70-82. doi:10.1139/bcb-2019-0060. https://pubmed.ncbi.nlm.nih.gov/30965010/
Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest